Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressing neurodegenerative disease characterized by upper and lower motor neuron degeneration. Degeneration of upper motor neurons occurs in the corticospinal tract and lower motor neurons occurs in the plexuses that innervate the skeletal muscles. Patients experience systemic muscle weakness, dysphagia, and spasticity that ultimately results in respiratory failure. ALS diminishes the quality of life of patients and, in the majority of cases, leads to death within 3-5 years of diagnosis. The promise of using disease-modifying drugs to slow ALS progression has caused neuroregeneration research to invigorate. Stem cell treatment is one of the new ALS disease-modifying therapies that can be offered at a stem cell clinic Bangkok. Because a stem cell injection for ALS has the potential to decrease the disease progression significantly beyond the available pharmacological therapies, it’s a game-changing treatment option for patients.
The available pharmacological therapies for ALS have negative side effects and only extend the life of a patient by 3-6 months. Riluzole and Edaravone are the only drugs available to slow the progression of ALS. While awaiting the advent of disease-modifying drugs, or considering a stem cell injection for ALS at a stem cell clinic Bangkok, ALS patients are offered multi-disciplinary support therapy to assist the patient with the mechanical support of their respiratory muscles. Nutritional support and physical rehabilitation are offered to manage the muscle contractures and the inflammation of the muscles. Traditional muscle relaxants may even fail to manage the disease spasticity without causing generalized muscle weakness. Given the rigid constraints of contemporary medicine, many patients explore alternative neurorestorative options. For patients with rapid functional decline, a stem cell clinic Bangkok can provide experimental, yet, scientifically based biological methods, including a stem cell injection for ALS. Therefore, a recent review by the medical research community examines the use of stem cells for ALS to untangle and address the challenges of complex multi-factorial disease processes.
In order to appreciate the full extent of these regenerative methods, one must appreciate the biological uniqueness of the cells themselves. Stem cells are unspecialized and opportunistically primitive cells that can replicate themselves and can even differentiate, when needed, into specialized cell types that are necessary to maintain physiology. The local environment surrounding these cells is of the utmost importance for their survival after implantation. Natural biomaterials, along with some synthetic polymers, serve as scaffolds to add the necessary structure for stabilizing the tissue engineering processes. These scaffolds must be highly porous to allow the passage of nutrients and must be of a variable permeability to allow the pace of new tissue growth to match the engineering process. The research focus in the area of neurological pathology is on the design and engineering of specialized soft hydrogel matrices that can be readily injected into selected neural pathways. In keeping with the emerging paradigm of cellular engineering, any modern medical facility must be able to isolate, expand, purify, and spatially organize the cellular elements prior to their implantation to maintain their fundamental properties as stem cells. The degree of purification of the cellular elements is a function of their structural plasticity. Recent studies present a critical review of the variable outcomes of cell-based interventions, which helps guide protocols for a stem cell injection for ALS at a stem cell clinic Bangkok.
A clinical review of one case involves a patient who underwent embryonic stem cell therapy abroad, resulting in rapid functional decline in the six months following the therapy. This illustrates the complexity of biochemistry involved in choosing cell types, dosing, and the route of administration. A pioneering first-in-human clinical trial involving a conditioned medium from human exfoliated deciduous teeth, however, led to positive clinical outcomes. Following transnasal and intravenous administration, the patient improved clinically with an increased range of motion in joints, stabilization of pulmonary functions, and improved functional rating scores, which remained unchanged over a long period after the therapy. This trial provides positive evidence for cell-free secretome therapies and, to a lesser extent, a stem cell injection for ALS, as they may potentially avoid the immune response caused by cellular engraftment. The patient in the trial regained activities of daily living, with no adverse effects of the therapy, thus proving that the therapy was safe. Patients seeking stem cell therapies marketed as “safe” and “advanced” at a stem cell clinic Bangkok may actually receive therapies explained by the rigorous safety and ethical standards rather than the unsubstantiated commercial claims.
Great therapeutic progress of these advanced biologics, such as a stem cell injection for ALS provided by a stem cell clinic Bangkok, is partially due to strong molecular interactions and therapeutic effects. Instead of direct cell replacement, research has shown that cells of mesenchymal lineage have significant paracrine effects. Transendosomal therapeutic effects of the conditioned medium may be due to the presence of bioactive cytokines, therapeutic exosomes, and neurotrophic factors. At the deep molecular level, certain components including Brain-Derived Neurotrophic Factor, Glial Cell-Derived Neurotrophic Factor, and Vascular Endothelial Growth Factor prevent developmental cell death and promote neurogenesis. The secretome used in this study also actively changes the neuroinflammatory environment associated with rapid degeneration of motor neurons. Hepatocyte Growth Factor and the secreted ectodomain of sialic acid-binding Ig-like lectin-9 are examples of immunomodulatory agents that when used together, change the functional orientation of microglia. This change decreases the localized oxidative stress and neurotoxicity, as the aggressive inflammatory M1 macrophages are transformed into the M2 macrophage phenotype. An in-depth understanding of these signaling pathways will help optimize the therapeutic protocols of any stem cell clinic Bangkok. The stem cell injection for ALS offered at these clinics, as a protective measure for the neural networks, utilizes these pathways.
Figure 1: Modern regenerative medicine to optimizing therapy for ALS
As a result of the rapid and cutting-edge advances in regenerative medicine, Thailand is becoming a global leader in this area of specialization. The combination of the ability to conduct and publish quality research without losing the ability to conduct clinical research offers the unique opportunity for significant advancements in the field of neurology. The combined efforts of the local scientists and clinicians have created unique neural scaffolds used in conjunction with signaling molecules. Thailand has a rich network of clinics, including any premier stem cell clinic Bangkok, that provide complete rehabilitation and therapeutic services, which can easily be combined with some of the most advanced techniques in regenerative medicine, such as a stem cell injection for ALS.
A thorough healthcare system that incorporates bespoke molecular therapies—like a stem cell injection for ALS administered at a stem cell clinic Bangkok—and deliberate physiotherapeutic practices has been shown to be beneficial to these patients. As an ongoing review of exosome cargo manipulation continues, the reversal of damage to motor neurons becomes a real possibility.